Search Results - "Malekzadeh, Katty"
-
1
Factors Associated with Survival in Anaplastic Thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF Network
Published in Thyroid (New York, N.Y.) (01-10-2023)“…Anaplastic thyroid carcinoma (ATC) is a rare and frequently fatal type of thyroid cancer. The degree of heterogeneity in survival rates for ATC is incompletely…”
Get more information
Journal Article -
2
-
3
Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: A European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma study
Published in European journal of cancer (1990) (01-01-2014)“…Abstract Purpose To assess objective response rate (ORR) after two cycles of temozolomide in combination with topotecan (TOTEM) in children with refractory or…”
Get full text
Journal Article -
4
Evaluation of whole body MRI for early detection of cancer in TP53 mutation carriers: Final results of the LIFSCREEN study
Published in Journal of clinical oncology (20-05-2018)“…Abstract only…”
Get full text
Journal Article -
5
Abstract A51: Phase I, safety, tolerability and preliminary efficacy study of Tremelimumab (Trem) in combination with Gefitinib (Gef) in EGFR-mutant (EGFR-mut) NSCLC (GEFTREM)
Published in Molecular cancer therapeutics (01-12-2015)“…Background: Robust advances in our understanding of NSCLC molecular biology and host immunity have expanded the field of cancer therapy with new…”
Get full text
Journal Article -
6
Dose-finding study of vinblastine in combination with nilotinib in children, adolescents and young adults with refractory or recurrent low-grade glioma: Results of the ITCC/SIOPE-Brain VINILO phase I trial (NCT01887522)
Published in Journal of clinical oncology (20-05-2016)“…Abstract only…”
Get full text
Journal Article -
7
Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumors
Published in Journal of clinical oncology (20-05-2015)“…Abstract only…”
Get full text
Journal Article -
8
Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma and other pediatric solid malignancies: A European ITCC study
Published in Journal of clinical oncology (20-05-2012)“…Abstract only 9517 Background: Temozolomide and topotecan have shown activity in several pediatric cancers, including neuroblastoma. Resistance to alkylating…”
Get full text
Journal Article